使用反向脆弱指数评估血管外科阴性随机对照试验的稳健性
本研究检索 MEDLINE 和 Embase,纳入以统计学非显著二分类结局为主要终点的腹主动脉瘤、颈动脉狭窄和下肢外周动脉疾病血管外科随机对照试验,计算反向脆弱指数(RFI)。共纳入 49 项研究、103 个不同主要终点,总体中位 RFI 为 7;在 103 个终点中,42 个(47%)的失访例数大于其 RFI。
要点
- 总体中位反向脆弱指数为 7(四分位距 5-13)。
- 腹主动脉瘤、颈动脉狭窄、下肢外周动脉疾病的中位 RFI 分别为 10、6、7。
- 103 个终点中 42 个(47%)的失访例数大于其 RFI。
核心结论
- 少数事件转换(中位 7 例)即可使阴性随机对照试验的统计学非显著结局转为显著,47% 的研究存在可能逆转其主要结局的缺失数据。
- 作者认为,报告 RFI 相对于失访的情况可能对今后试验有益,并可增强对 P 值稳健性的信心。
研究设计与样本
- 研究检索 MEDLINE 和 Embase,纳入比较血管腔内与开放手术治疗腹主动脉瘤、颈动脉狭窄和下肢外周动脉疾病、且主要二分类结局为统计学非显著的随机对照试验。
- 从 4187 篇报告中纳入 49 项研究,共报告 103 个不同主要终点。
主要发现
- 总体中位 RFI 为 7(四分位距 5-13)。
- 腹主动脉瘤、颈动脉狭窄和下肢外周动脉疾病的中位 RFI 分别为 10(四分位距 6-15.5)、6(四分位距 5-9.5)和 7(四分位距 5.5-10)。
- 103 个终点中有 42 个(47%)的失访例数大于其 RFI,其中腹主动脉瘤试验 10 项(24%)、颈动脉狭窄试验 23 项(55%)、下肢外周动脉疾病试验 9 项(21%)。
- 研究 RFI 与发表期刊影响因子呈显著正相关(r=0.38;95%CI 0.20-0.54;P<.01),与随访时长呈显著正相关(r=0.43;95%CI 0.26-0.58;P<.01),与样本量呈显著正相关(r=0.28;95%CI 0.09-0.45;P<.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The reverse fragility index (RFI) describes the number of event conversions needed to convert a statistically nonsignificant dichotomous outcome to a significant one. The objective of the present study was to assess the RFI of vascular surgery randomized controlled trials (RCTs) comparing endovascular vs open surgery for the treatment of abdominal aortic aneurysms (AAAs), carotid artery stenosis (CAS), and peripheral artery disease (PAD). METHODS: MEDLINE and Embase were searched for RCTs that had investigated AAAs, CAS, or PAD with statistically nonsignificant binary primary outcomes. The primary outcome for the present study was the median RFI. Calculation of the RFI was performed by creating two-by-two contingency tables and subtracting events from the group with fewer events and adding nonevents to the same group until a two-tailed Fisher exact test had produced a statistically significant result (P ≤ .05). RESULTS: Of 4187 reports, 49 studies reporting 103 different primary end points were included. The overall median RFI was 7 (interquartile range [IQR], 5-13). The specific RFIs for AAA, CAS, and PAD were 10 (IQR, 6-15.5), 6 (IQR, 5-9.5), and 7 (IQR, 5.5-10), respectively. Of the 103 end points, 42 (47%) had had a loss to follow-up greater than the RFI, of which 10 were AAA trials (24%), 23 were CAS trials (55%), and 9 were PAD trials (21%). The Pearson correlation demonstrated a significant positive relationship between a study's RFI and the impact factor of its publishing journal (r = 0.38; 95% confidence interval [CI], 0.20-0.54; P < .01), length of follow-up (r = 0.43; 95% CI, 0.26-0.58; P < .01), and sample size (r = 0.28; 95% CI, 0.09-0.45; P < .01). CONCLUSIONS: A small number of events (median, 7) was required to change the outcome of negative RCTs from statistically nonsignificant to significant, with 47% of the studies having missing data that could have reversed the finding of its primary outcome. Reporting of the RFI relative to the loss to follow-up could be of benefit in future trials and provide confidence regarding the robustness of the P value.
引用
- Li A, Javidan AP, Liu E, et al. Assessing the robustness of negative vascular surgery randomized controlled trials using their reverse fragility index. J Vasc Surg. 2022. PMID: 36572321. doi:10.1016/j.jvs.2022.12.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。